HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meg J Jardine Selected Research

Canagliflozin

1/2022Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial.
1/2022The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial.
1/2022Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial.
1/2022Renal, cardiovascular and safety outcomes of canagliflozin in patients with type 2 diabetes and nephropathy in East and South-East Asian countries: Results from the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation Trial.
12/2021Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial.
12/2021Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis.
7/2021Canagliflozin, serum magnesium and cardiovascular outcomes-Analysis from the CANVAS Program.
1/2021Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis.
1/2021Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice.
1/2021Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Meg J Jardine Research Topics

Disease

29Type 2 Diabetes Mellitus (MODY)
01/2022 - 11/2012
23Chronic Renal Insufficiency
01/2022 - 09/2009
17Kidney Diseases (Kidney Disease)
01/2022 - 06/2012
15Renal Insufficiency (Renal Failure)
01/2022 - 06/2013
14Chronic Kidney Failure (Chronic Renal Failure)
01/2022 - 06/2012
12Albuminuria
01/2021 - 11/2012
10Heart Failure
04/2022 - 01/2019
9Stroke (Strokes)
04/2022 - 02/2013
8Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 06/2014
7Myocardial Infarction
04/2022 - 02/2013
5Thrombosis (Thrombus)
05/2016 - 06/2012
4Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 12/2019
4Hemorrhage
01/2022 - 02/2013
4Infections
01/2022 - 01/2017
3Proteinuria
01/2022 - 01/2017
3IGA Glomerulonephritis (IGA Nephropathy)
01/2022 - 01/2017
3Body Weight (Weight, Body)
01/2021 - 01/2019
2Acute Kidney Injury (Acute Renal Failure)
01/2022 - 11/2019
2Hypertension (High Blood Pressure)
01/2021 - 09/2010
2Diabetes Mellitus
01/2020 - 01/2019
2Inflammation (Inflammations)
01/2020 - 01/2019
2Malnutrition (Nutritional Deficiencies)
01/2020 - 01/2019
2Hyperkalemia
01/2020 - 01/2019
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
01/2022
1Diabetic Neuropathies (Diabetic Neuropathy)
01/2022
1Osteoporosis
01/2022
1Polyneuropathies (Polyneuropathy)
01/2022
1Nervous System Diseases (Neurological Disorders)
12/2021
1Heart Diseases (Heart Disease)
12/2021
1Atrial Fibrillation
01/2021
1Vascular Calcification
11/2020
1Hyperphosphatemia
11/2020
1Foot Diseases
10/2020
1Restless Legs Syndrome (Restless Legs)
01/2020
1Hypotension (Low Blood Pressure)
01/2020
1Hypokalemia
01/2020
1Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets)
12/2019
1Uremia
01/2019
1Anemia
01/2019
1Peripheral Nervous System Diseases (PNS Diseases)
01/2019
1Pulmonary Embolism
05/2016
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
05/2016
1Venous Thrombosis (Deep-Vein Thrombosis)
05/2016
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
05/2016
1Sepsis (Septicemia)
04/2016

Drug/Important Bio-Agent (IBA)

26CanagliflozinIBA
01/2022 - 12/2017
16CreatinineIBA
01/2022 - 11/2012
10Sodium-Glucose Transporter 2 InhibitorsIBA
01/2021 - 01/2019
9Glucose (Dextrose)FDA LinkGeneric
01/2022 - 10/2018
8AlbuminsIBA
01/2021 - 12/2017
7Sodium-Glucose Transport ProteinsIBA
01/2022 - 01/2019
7SodiumIBA
01/2022 - 01/2019
3Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2022 - 02/2013
3MethylprednisoloneFDA LinkGeneric
01/2022 - 01/2017
3PotassiumIBA
12/2021 - 01/2019
3SymportersIBA
01/2021 - 01/2019
3Pharmaceutical PreparationsIBA
01/2021 - 10/2018
3AnticoagulantsIBA
01/2019 - 11/2013
3HomocysteineIBA
05/2016 - 06/2012
2omega-Chloroacetophenone (Mace)IBA
04/2022 - 01/2021
2DiureticsIBA
01/2021 - 01/2021
2Glucagon-Like Peptide-1 Receptor AgonistsIBA
01/2021 - 11/2020
2SteroidsIBA
01/2021 - 01/2017
2Phosphates (Orthophosphate)IBA
11/2020 - 12/2019
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2017 - 06/2013
2Warfarin (Coumadin)FDA LinkGeneric
04/2016 - 11/2013
1GlucocorticoidsIBA
01/2022
1MineralsIBA
01/2022
1MagnesiumIBA
07/2021
1Dipeptidyl-Peptidase IV InhibitorsIBA
01/2021
1Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA
01/2021
1Fibroblast Growth Factor-23IBA
11/2020
1HematinicsIBA
11/2020
1Angiotensin Receptor AntagonistsIBA
01/2020
1dapagliflozinIBA
01/2020
1Serum AlbuminIBA
01/2020
1Mineralocorticoid Receptor AntagonistsIBA
01/2020
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2020
1Parathyroid Hormone (Parathormone)IBA
12/2019
1CalciumIBA
12/2019
12-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA
01/2019
1Dietary SodiumIBA
01/2019
1Vitamin KFDA Link
01/2019
1SaltsIBA
01/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2017

Therapy/Procedure

14Therapeutics
01/2022 - 09/2009
5Renal Dialysis (Hemodialysis)
01/2021 - 01/2013
3Hemodiafiltration
01/2021 - 01/2013
3Transplantation
01/2021 - 01/2019
3Renal Replacement Therapy (Therapies, Renal Replacement)
05/2015 - 06/2012
2Drug Tapering
01/2022 - 01/2019
2Kidney Transplantation
01/2021 - 01/2009
2Surgical Amputation (Amputations)
10/2020 - 05/2016
2Catheters
04/2016 - 11/2013
1Antibiotic Prophylaxis
01/2022
1Plant-Based Diet
01/2020
1Diet Therapy (Therapy, Diet)
01/2020
1Secondary Prevention
01/2019
1Glycemic Control
10/2017
1Hemofiltration
06/2014